Catechol estrogens induce proliferation and malignant transformation in prostate epithelial cells

Toxicology Letters

Volumn 220, Issue 3, 2013, Pages 247-258

  Mosli, Hisham A ^a   Tolba, Mai F ^b   Al Abd, Ahmed M ^c,d   Abdel Naim, Ashraf B ^b,c  

^a King Abdulaziz University   (Saudi Arabia)

^b African Union Organization St Abbassia   (Egypt)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^d NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Carcinogenesis; Catechol estrogens; Estrogen; Prostate

Indexed keywords

2 HYDROXYESTRADIOL; 4 HYDROXYESTRADIOL; AGAR; CYCLIN D1; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MYC PROTEIN; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR FKHR;

ARTICLE; CARCINOGENICITY; CELL INVASION; CELL PROLIFERATION; COLONY FORMING CELL; COMET ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; FLUORESCENCE ACTIVATED CELL SORTING; GENOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROSTATE EPITHELIUM;

CELL CYCLE; CELL LINE; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COMET ASSAY; DNA DAMAGE; EPITHELIAL CELLS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS, CATECHOL; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATE; PROSTATIC NEOPLASMS; RECEPTOR, IGF TYPE 1;

EID: 84879466593     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2013.05.002     Document Type: Article

References (42)

1. Albini A., Iwamoto Y., Kleinman H.K., Martin G.R., Aaronson S.A., Kozlowski J.M., McEwan R.N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Research 1987, 47:3239-3245.
2. Bernstein L. The epidemiology of breast cancer. LOWAC Journal 1998, 1:7-13.
3. Bosland M.C. The role of steroid hormones in prostate carcinogenesis. Journal of the National Cancer Institute Monographs 2000, 27:39-66.
4. Bostwick D.G., Burke H.B., Djakiew D., Euling S., Ho S.M., Landolph J., Morrison H., Sonawane B., Shifflett T., Waters D.J., Timms B. Human prostate cancer risk factors. Cancer 2004, 101(Suppl. 10):2371-2490.
5. Carruba G. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario. Journal of Cellular Biochemistry 2007, 102:899-911.
6. Cavalieri E., Chakravarti D., Guttenplan J., Hart E., Ingle J., Jankowiak R., Muti P., Rogan E., Russo J., Santen R., Sutter T. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochimica et Biophysica Acta 2006, 1766:63-78.
7. Cavalieri E., Frenkel K., Liehr J.G., Rogan E., Roy D. Estrogens as endogenous genotoxic agents: DNA adducts and mutations. JNCI Monograph 27: Estrogens as Endogenous Carcinogens in the Breast and Prostate 2000, 75-93. Oxford University Press, Oxford. E. Cavalieri, E. Rogan (Eds.).
8. Cavalieri E., Rogan E., Chakravarti D. The role of endogenous catechol quinones in the initiation of cancer and neurodegenerative diseases. Methods in Enzymology, Quinones and Quinone Enzymes 2004, vol. 382:293-319. Elsevier, Duesseldorf, Germany.
9. Cavalieri E.L., Stack D.E., Devanesan P.D., Todorovic R., Dwivedy I., Higginbotham S., Johansson S.L., Patil K.D., Gross M.L., Gooden J.K., Ramanathan R., Cerny R.L., Rogan E.G. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:10937-10942.
10. Cavalieri E.L., Devanesan P., Bosland M.C., Badawi A.F., Rogan E.G. Catechol estrogen metabolites and conjugates in different regions of the prostate of Noble rats treated with 4-hydroxyestradiol: implications for estrogen-induced initiation of prostate cancer. Carcinogenesis 2002, 23:329-333.
11. Ellem S.J., Risbridger G.P. The dual, opposing roles of estrogen in the prostate. Annals of the New York Academy of Sciences 2009, 1155:174-186.
12. Cussenot O., Azzouzi A.R., Nicolaiew N., Fromont G., Mangin P., Cormier L., Fournier G., Valeri A., Larre S., Thibault F., Giodanella J.P., Pouchard M., Zheng Y., Hamdy F.C., Cox A., Cancel-Tassin G. Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens. Journal of Clinical Oncology 2007, 25:3596-3602.
13. Feigelson H.S., Henderson B.E. Estrogens and breast cancer. Carcinogenesis 1996, 17:2279-2284.
14. Fernandez S.V., Russo I.H., Russo J. Estradiol and its metabolites 4-hydroxyestradiol and 2-hydroxyestradiol induce mutations in human breast epithelial cells. International Journal of Cancer 2006, 118:1862-1868.
15. Fujimura T., Takahashi S., Urano T., Ijichi N., Ikeda K., Kumagai J., Murata T., Takayama K., Horie-Inoue K., Ouchi Y., Muramatsu M., Homma Y., Inoue S. Differential expression of estrogen-related receptors beta and gamma (ERRbeta and ERRgamma) and their clinical significance in human prostate cancer. Cancer Science 2010, 101:646-651.
16. Greenwald P., Caputo T.A., Wolfgang P.E. Endometrial cancer after menopausal use of estrogens. Obstetrics and Gynecology 1977, 50:239-243.
17. Ho S.M. Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates. Journal of Cellular Biochemistry 2004, 91:491-503.
18. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 1987, vol. 7:280-285. IARC, Lyon, France.
19. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Hormonal Contraception and Postmenopausal Hormone Therapy 1999, 72. IARC, Lyon, France.
20. Lau K.-M., LaSpina M., Long J., Ho S.-M. Expression of estrogen receptor (ER)-a and ER-b in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation. Cancer Research 2000, 60:3175-3182.
21. Li K.-M., Todorovic R., Devanesan P., Higginbotham S., Köfeler H., Ramanathan R., Gross M.L., Rogan E.G., Cavalieri E.L. Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo. Carcinogenesis 2004, 25:289-297.
22. Luo Y., Waladali W., Li S., Zheng X., Hu L., Zheng H., Hu W., Chen C. 17-Beta-estradiol affects proliferation and apoptosis of rat prostatic smooth muscle cells by modulating cell cycle transition and related proteins. Cell Biology International 2008, 32:899-905.
23. Mawhinney M.G., Belis J.A. Androgens and estrogens in prostatic neoplasia. Advances in Sex Hormone Research 1976, 2:141-209.
24. Mongr I. Post-menopausal estrogen therapy. Evaluation of Carcinogenic Risks to Humans 1992, 72:399-530.
25. Mosli H.A., Al-Abd A.M., El-Shaer M.A., Khedr A., Gazzaz F.S., Abdel-Naim A.B. Local inflammation influences oestrogen metabolism in prostatic tissue. BJU International 2011, 110:274-282.
26. Mueck A.O., Seeger H. Breast cancer: are oestrogen metabolites carcinogenic?. Maturitas 2007, 57:42-46.
27. Nakajima Y., Akaogi K., Suzuki T., Osakabe A., Yamaguchi C., Sunahara N., Ishida J., Kako K., Ogawa S., Fujimura T., Homma Y., Fukamizu A., Murayama A., Kimura K., Inoue S., Yanagisawa J. Estrogen regulates tumor growth through a nonclassical pathway that includes the transcription factors ERbeta and KLF5. Science Signaling 2011, 4:ra22.
28. Nock N.L., Cicek M.S., Li L., Liu X., Rybicki B.A., Moreira A., Plummer S.J., Casey G., Witte J.S. Polymorphisms in estrogen inactivation, detoxification and oxidative DNA base excision repair genes and prostate cancer risk. Carcinogenesis 2006, 27:1842-1848.
29. Prezioso D., Denis L.J., Klocker H., Sciarra A., Reis M., Naber K., Lobel B., Pacik D., Griffiths K. Estrogens and aspects of prostate disease. International Journal of Urology 2007, 14:1-16.
30. Ricke W.A., McPherson S.J., Bianco J.J., Cunha G.R., Wang Y., Risbridger G.P. Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling. FASEB Journal 2008, 22:1512-1520.
31. Rossi V., Bellastella G., De Rosa C., Abbondanza C., Visconti D., Maione L., Chieffi P., Della Ragione F., Prezioso D., De Bellis A., Bellastella A., Sinisi A.A. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor alpha and beta. Journal of Cellular Physiology 2011, 226:1334-1339.
32. Russo J., Lareef M.H., Tahin Q., Hu Y.F., Slater C., Ao X., Russo I.H. 17-Beta-estradiol is carcinogenic in human breast epithelial cells. Journal of Steroid Biochemistry and Molecular Biology 2002, 80:149-162.
33. Salama S.A., Kamel M., Awad M., Nasser A.H., Al-Hendy A., Botting S., Arrastia C. Catecholestrogens induce oxidative stress and malignant transformation in human endometrial glandular cells: protective effect of catechol-O-methyltransferase. International Journal of Cancer 2008, 123:1246-1254.
34. Salama S.A., Kamel M.W., Botting S., Salih S.M., Borahay M.A., Hamed A.A., Kilic G.S., Saeed M., Williams M.Y., Diaz-Arrastia C.R. Catechol-o-methyltransferase expression and 2-methoxyestradiol affect microtubule dynamics and modify steroid receptor signaling in leiomyoma cells. PLoS ONE 2009, 4:e7356.
35. Siiteri P.K., Nisker J.A., Hammond G.L. Hormonal Basis of Risk Factors for Breast and Endometrial Cancer 1980, 499-505. Hormones and Cancer Raven Press, NY, USA. S. Iacobelli, K.R. Lindner, H.R.M.E. Lippman (Eds.).
36. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Experimental Cell Research 1988, 175:184-191.
37. Singh P.B., Matanhelia S.S., Martin F.L. A potential paradox in prostate adenocarcinoma progression: oestrogen as the initiating driver. European Journal of Cancer 2008, 44:928-936.
38. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J.T., Bokesch H., Kenney S., Boyd M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. Journal of the National Cancer Institute 1990, 82:1107-1112.
39. Tanaka Y., Sasaki M., Shiina H., Tokizane T., Deguchi M., Hirata H., Hinoda Y., Okayama N., Suehiro Y., Urakami S., Kawakami T., Kaneuchi M., Pookot D., Igawa M., Okuyama A., Ishii N., Dahiya R. Catechol-O-methyltransferase gene polymorphisms in benign prostatic hyperplasia and sporadic prostate cancer. Cancer Epidemiology, Biomarkers and Prevention 2006, 15:238-244.
40. Yu L., Shi J., Cheng S., Zhu Y., Zhao X., Yang K., Du X., Klocker H., Yang X., Zhang J. Estrogen promotes prostate cancer cell migration via paracrine release of ENO1 from stromal cells. Molecular Endocrinology 2012, 26:1521-1530.
41. Yu S., Zhang Y., Yuen M.T., Zou C., Danielpour D., Chan F.L. 17-Beta-estradiol induces neoplastic transformation in prostatic epithelial cells. Cancer Letters 2011, 304:8-20.
42. Zhou D., Li S., Wang X., Cheng B., Ding X. Estrogen receptor alpha is essential for the proliferation of prostatic smooth muscle cells stimulated by 17-β-estradiol and insulin-like growth factor 1. Cell Biochemistry and Function 2011, 29:120-125.